StockNews.AI
FLGT
StockNews.AI
95 days

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc

1. Wolf Haldenstein is investigating Fulgent Genetics for potential securities fraud. 2. Fulgent disclosed receiving a DOJ investigative demand on February 28, 2025. 3. The investigation may involve false claims under the Uninsured Program. 4. Wolf Haldenstein has over 125 years of experience in investor rights protection. 5. This news raises concerns about Fulgent's compliance and transparency.

3m saved
Insight
Article

FAQ

Why Very Bearish?

Securities fraud investigations can lead to significant stock declines, as seen with other companies. The involvement of the DOJ adds substantial risk and uncertainty.

How important is it?

The DOJ's investigation directly affects investor confidence and may lead to regulatory scrutiny. Legal issues often have a profound impact on stock performance.

Why Short Term?

Immediate investor sentiment may drop due to concerns over legal implications. Similar past incidents typically show quick reactions from the market.

Related Companies

ALNYDXCMSGEN
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fulgent Genetics, Inc. (NASDAQ: FLGT). Key Details: Subject of Investigation: Whether Fulgent Genetics and certain officers/directors engaged in securities fraud.On February 28, 2025, Fulgent disclosed in its Form 10-K that it had received a civil investigative demand from the Department of Justice (DOJ) regarding potential false claims submitted under the Uninsured Program.Wolf Haldenstein: This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors. Contact Information Firm: Wolf Haldenstein Adler Freeman & Herz LLP Primary Contact: Gregory Stone, Director of Case and Financial Analysis Email: mailto:gstone@whafh.com or classmember@whafh.com Phone: (800) 575-0735 or (212) 545-4774 This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Related News